Insider Trading History of Wentworth Kerry

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Wentworth Kerry since 2019. This trader's CIK number is 1369453. At the time of last reporting, Wentworth Kerry was the CHIEF REGULATORY OFFICER of Nuvation Bio Inc.. (stock ticker symbol NUVB). Also see all insider trading activities at Nuvation Bio Inc..

Note that in the past Wentworth Kerry also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Flexion Therapeutics Inc (FLXN) by Wentworth Kerry

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 FLXN 0 $0 10,773 $101,444 0 $0
2020 FLXN 0 $0 3,724 $0 0 $0
2019 FLXN 0 $0 622 $7,687 3,400 $0

Yearly summary of insider trading at Nuvation Bio Inc. (NUVB) by Wentworth Kerry

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 NUVB 50,000 $89,750 0 $0 0 $0


Insider trading activities at 2 companies by Wentworth Kerry:

1. Flexion Therapeutics Inc (FLXN)

2. Nuvation Bio Inc. (NUVB)

Table 1. Insider trading of Flexion Therapeutics Inc (FLXN) by Wentworth Kerry

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-07-19 FLXN Sale 3,944 6.45 25,438
2021-01-05 FLXN Sale 6,829 11.13 76,006
2020-01-03 FLXN Sale 3,724 .00 0
2019-10-06 FLXN Option Ex 3,400 .00 0
2019-01-03 FLXN Sale 622 12.36 7,687

Table 2. Insider trading of Nuvation Bio Inc. (NUVB) by Wentworth Kerry

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-16 NUVB Buy 50,000 1.79 89,750

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wentworth Kerry (CHIEF REGULATORY OFFICER of Nuvation Bio Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.